|
"tseng ch"的相關文件
顯示項目 181-190 / 271 (共28頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2013-01-04 |
Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: A population-based cohort study using the National Health Insurance in Taiwan
|
Tseng, CH |
| 臺北醫學大學 |
2013 |
The evaluation of microtube array membrane
|
Tseng, CH;Chiu, CC;Chang, CT;Chen, KS;Hsiao, G;Chen, CC |
| 高雄醫學大學 |
2013 |
合成Aminoalkoxy 4,5-Diphenylisoxazole 作為抗骨質疏鬆試劑
|
陳義龍;曾志華;羅友志;林儒緯;陳建復;王國照;何美泠;曾誠齊; Chen, YL;Tseng, CH;Lo, YC;Lin, RW;Chen, CF;Wang, GJ;Ho, ML;CC , Tzeng |
| 國家衛生研究院 |
2012-12-27 |
Thyroid cancer risk is not increased in diabetic patients
|
Tseng, CH |
| 國家衛生研究院 |
2011-01 |
Blackfoot disease and microcirculation abnormality
|
Tseng, CH;Chong, CK;Hsueh, YM;Chiou, HY;Wang, SL;Chen, CJ |
| 高雄醫學大學 |
2011 |
4-Anilinofuro[2,3-b]quinoline衍生物的合成、藥物動力學及抗癌活性評估
|
陳郁旻;陳義龍;曾志華;梁治中;楊佳寧;姚雲欽;呂配融;曾誠齊; Chen YW;Chen YL;Tseng CH;Liang CC;Yang CN;Yao YC;Lu PJ;Tzeng CC |
| 高雄醫學大學 |
2011 |
發現茚並[1,2-C]喹啉衍生物為受體激活NF-b配體（RANKL）誘導破骨細胞抑製劑
|
曾志華;林儒偉;陳義龍;王國照;何美泠; , 曾誠齊; Tseng, CH;Lin, RW;Chen, YL;Wang, GJ;Ho, ML; , Tzeng CC |
| 國家衛生研究院 |
2010-12 |
A recombinant peroxisome proliferator response element-driven luciferase assay for evaluation of potential environmental obesogens
|
Wang, YF;Chao, HR;Wu, CH;Tseng, CH;Kuo, YT;Tsou, TC |
| 國家衛生研究院 |
2010-12 |
Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan
|
Chang, HY;Hsu, CC;Pan, WH;Liu, WL;Cheng, JYC;Tseng, CH;Bai, CH;Yeh, WT;Hurng, BS |
| 國家衛生研究院 |
2010-08-17 |
Betel nut chewing and incidence of newly diagnosed type 2 diabetes mellitus in Taiwan
|
Tseng, CH |
顯示項目 181-190 / 271 (共28頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目
|
